Annual Shareholders Equity
$60.35 M
-$63.02 M-51.08%
31 March 2022
Summary:
Sio Gene Therapies annual stockholders equity is currently $60.35 million, with the most recent change of -$63.02 million (-51.08%) on 31 March 2022. During the last 3 years, it has fallen by -$63.02 million (-51.08%).SIOX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$45.12 M
-$3.79 M-7.75%
31 December 2022
Summary:
Sio Gene Therapies quarterly stockholders equity is currently $45.12 million, with the most recent change of -$3.79 million (-7.75%) on 31 December 2022.SIOX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SIOX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -51.1% | -40.8% |
| 5 y5 years | +7.4% | +794.0% |
SIOX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -77.4% | -86.0% |
Sio Gene Therapies Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $45.12 M(-7.8%) |
| Sept 2022 | - | $48.91 M(-5.5%) |
| June 2022 | - | $51.78 M(-14.2%) |
| Mar 2022 | $60.35 M(-51.1%) | $60.35 M(-20.9%) |
| Dec 2021 | - | $76.27 M(-23.2%) |
| Sept 2021 | - | $99.36 M(-12.3%) |
| June 2021 | - | $113.30 M(-8.2%) |
| Mar 2021 | $123.37 M(+100.4%) | $123.37 M(+38.6%) |
| Dec 2020 | - | $89.03 M(+27.8%) |
| Sept 2020 | - | $69.67 M(+18.9%) |
| June 2020 | - | $58.58 M(-4.8%) |
| Mar 2020 | $61.56 M(+9.5%) | $61.56 M(+1119.7%) |
| Dec 2019 | - | $5.05 M(-70.4%) |
| Sept 2019 | - | $17.04 M(-41.9%) |
| June 2019 | - | $29.35 M(-47.8%) |
| Mar 2019 | $56.21 M | $56.21 M(+147.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | - | $22.76 M(+14.5%) |
| Sept 2018 | - | $19.88 M(-23.0%) |
| June 2018 | - | $25.83 M(-63.8%) |
| Mar 2018 | $71.29 M(-42.9%) | $71.29 M(-33.2%) |
| Dec 2017 | - | $106.65 M(-30.4%) |
| Sept 2017 | - | $153.18 M(-25.7%) |
| June 2017 | - | $206.20 M(+65.2%) |
| Mar 2017 | $124.84 M(-53.2%) | $124.84 M(-25.0%) |
| Dec 2016 | - | $166.46 M(-19.2%) |
| Sept 2016 | - | $205.94 M(-14.3%) |
| June 2016 | - | $240.25 M(-9.9%) |
| Mar 2016 | $266.74 M(-3541.4%) | $266.74 M(-7.4%) |
| Dec 2015 | - | $287.99 M(-7.8%) |
| Sept 2015 | - | $312.29 M(-2.9%) |
| June 2015 | - | $321.73 M |
| Mar 2015 | -$7.75 M | - |
FAQ
- What is Sio Gene Therapies annual stockholders equity?
- What is the all time high annual shareholders equity for Sio Gene Therapies?
- What is Sio Gene Therapies quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Sio Gene Therapies?
What is Sio Gene Therapies annual stockholders equity?
The current annual shareholders equity of SIOX is $60.35 M
What is the all time high annual shareholders equity for Sio Gene Therapies?
Sio Gene Therapies all-time high annual stockholders equity is $266.74 M
What is Sio Gene Therapies quarterly stockholders equity?
The current quarterly shareholders equity of SIOX is $45.12 M
What is the all time high quarterly shareholders equity for Sio Gene Therapies?
Sio Gene Therapies all-time high quarterly stockholders equity is $321.73 M